Jianhua Zhou Selected Research

Lipids

1/2023	Novel theranostic approaches to neovascularized atherosclerotic plaques.
6/2022	Dihydromyricetin ameliorates diet-induced obesity and promotes browning of white adipose tissue by upregulating IRF4/PGC-1α.
5/2019	Circulating neuromedin U levels are similar in subjects with NGT and newly diagnosed T2DM and do not correlate with insulin secretion.
12/2018	Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianhua Zhou Research Topics

Disease

71	Neoplasms (Cancer) 10/2023 - 12/2007
17	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2009
12	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2011
10	Infections 10/2023 - 06/2008
8	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2009
7	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 05/2010
7	Carcinoma (Carcinomatosis) 08/2023 - 12/2002
7	Lymphatic Metastasis 01/2023 - 11/2009
7	Inflammation (Inflammations) 01/2022 - 04/2017
6	Carcinogenesis 01/2022 - 06/2012
5	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2009
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2016
5	Wounds and Injuries (Trauma) 01/2022 - 01/2017
5	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 08/2015 - 01/2002
4	COVID-19 01/2023 - 01/2020
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022 - 06/2012
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2016
3	Hypertension (High Blood Pressure) 04/2024 - 01/2014
3	Osteosarcoma (Osteogenic Sarcoma) 07/2023 - 08/2014
3	Thrombosis (Thrombus) 01/2023 - 06/2020
3	Fibrosis (Cirrhosis) 01/2023 - 10/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2009
3	Nasopharyngeal Carcinoma 01/2019 - 04/2002
3	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 01/2009
2	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2024 - 01/2023
2	Proteinuria 04/2024 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 01/2023
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2023 - 01/2021
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2018
2	Fever (Fevers) 01/2022 - 01/2014
2	Diarrhea 01/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2012
2	Hyperplasia 12/2021 - 01/2018
2	Hyperlipidemias (Hyperlipidemia) 06/2021 - 01/2018
2	Bone Resorption 06/2021 - 11/2020
2	Thyroid Nodule (Nodule, Thyroid) 04/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2017
2	Hemolysis 01/2021 - 01/2019
2	Adenocarcinoma of Lung 01/2021 - 01/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 07/2007
2	Glioma (Gliomas) 10/2019 - 01/2017
2	Non-alcoholic Fatty Liver Disease 04/2019 - 12/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2012
19	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
10	Messenger RNA (mRNA)IBA 11/2022 - 07/2004
7	RNA (Ribonucleic Acid)IBA 08/2023 - 03/2012
6	VaccinesIBA 03/2018 - 04/2002
5	Contrast MediaIBA 05/2023 - 05/2018
5	EnzymesIBA 11/2021 - 12/2014
5	CateninsIBA 01/2018 - 08/2014
4	Phenobarbital (Luminal)FDA Link 08/2023 - 01/2018
4	LipidsIBA 01/2023 - 12/2018
4	perfluorobutane (AI 700)IBA 01/2023 - 01/2022
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 12/2012
4	ParaffinIBA 01/2019 - 06/2012
3	Long Noncoding RNAIBA 01/2023 - 01/2020
3	CytokinesIBA 01/2022 - 01/2009
3	Circular RNAIBA 01/2021 - 04/2019
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 08/2016
3	LuciferasesIBA 01/2020 - 07/2004
3	Peptide Initiation Factors (Initiation Factor)IBA 01/2019 - 01/2017
2	SteroidsIBA 04/2024 - 01/2023
2	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 04/2023 - 01/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2023 - 01/2022
2	LigandsIBA 01/2023 - 01/2020
2	Estrogen ReceptorsIBA 01/2023 - 01/2020
2	Therapeutic UsesIBA 01/2023 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 05/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2017
2	GelatinIBA 01/2022 - 01/2017
2	HydrogelsIBA 12/2021 - 06/2019
2	Simvastatin (Zocor)FDA LinkGeneric 06/2021 - 01/2018
2	Capsules (Microcapsules)IBA 02/2021 - 01/2019
2	Competitive Endogenous RNAIBA 01/2021 - 01/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2020 - 11/2011
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 06/2002
2	ChromatinIBA 01/2020 - 01/2017
2	AndrogensIBA 01/2020 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2019 - 01/2017
2	AlbuminsIBA 01/2019 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018

Therapy/Procedure

24	Therapeutics 01/2024 - 12/2007
8	Drug Therapy (Chemotherapy) 07/2023 - 08/2009
5	Immunotherapy 01/2023 - 01/2009
3	Castration 01/2020 - 08/2016
3	Esophagectomy 01/2018 - 01/2009
2	Microbubbles 05/2023 - 11/2017
2	Plasmapheresis 03/2023 - 01/2019
2	Intravesical Administration 01/2023 - 12/2018
2	Precision Medicine 01/2023 - 01/2016
2	Cholecystectomy 01/2022 - 01/2022
2	Catheters 01/2022 - 01/2021
2	Radiofrequency Ablation 04/2021 - 01/2021
2	Ablation Techniques 04/2021 - 01/2021
2	Aftercare (After-Treatment) 01/2019 - 10/2011